Advisory Services Network, LLC Akebia Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.51 - $1.43 $13,770 - $38,610	27,000 New	27,000 $24,000
Q2 2022 Aug 02, 2022	SELL	$0.32 - $0.67 $12,580 - $26,341	-39,315 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$2.22 - $3.78 $1,110 - $1,890	-500 Reduced 1.26%	39,315 $110,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $13.08 $69,482 - $380,261	29,072 Added 270.61%	39,815 $100,000
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $26,399 - $65,935	6,439 Added 149.61%	10,743 $81,000
Q4 2019 Feb 04, 2020	BUY	$3.16 - $6.73 $13,600 - $28,965	4,304 New	4,304 $27,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $417M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.